Cortisol and 17-hydroxyprogesterone kinetics in saliva after oral administration of hydrocortisone in children and young adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

被引:35
作者
Gröschl, M [1 ]
Rauh, M [1 ]
Dörr, HG [1 ]
机构
[1] Univ Erlangen Nurnberg, Hosp Children & Adolescents, D-91054 Erlangen, Germany
关键词
D O I
10.1210/jc.87.3.1200
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have analyzed the kinetics of salivary cortisol (F) and 17-hydoxyprogesterone (170HP) after a single oral administration of hydrocortisone (HC; 10 mg; 0700 h) in healthy male volunteers (n = 10; 18-29 yr) and in patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (males, n = 7; females, n = 3; 8.5-20.4 yr). The HC doses, related to body surface area, ranged from 6.3-9.2 mg/m(2) in controls and from 4.2-10.7 mg/m(2) in CAH patients. Saliva was collected over 5 h (at intervals of 15-30 min), and the steroids were measured with adapted RIAs. In healthy controls, maximal cortisol values (250.3 +/- 35.9 nmol/liter) were reached after 30 min. Values showed a monophasic decrease. A t(1/2) of 94.5 min was calculated. The proportion of the HC dose in the total area under the curve was 71.2 +/- 3.2%. For 170HP, a monophasic decrease was found, with a minimum level of 48 +/- 27 pmol/liter after 300 min. In CAH patients the salivary steroid profiles showed individual kinetics (maximal cortisol values ranged from 107-726 nmol/liter). Here a monophasic decrease was found with a shorter t(1/2) of 56.4 min. The HC dose proportion in the area under the curve was 88.3 +/- 6%. 170HP showed biphasic courses with a decrease to the minimum 170HP level after 210 min at the latest and a subsequent gradual increase. Our findings of limited normalization of the adrenal cortex by oral HC administration underlines the necessity of optimizing therapy control and indicates the usefulness of kinetic studies for the judgement of therapy in CAH patients.
引用
收藏
页码:1200 / 1204
页数:5
相关论文
共 32 条
[1]   MONITORING TREATMENT IN CONGENITAL ADRENAL-HYPERPLASIA [J].
APPAN, S ;
HINDMARSH, PC ;
BROOK, CGD .
ARCHIVES OF DISEASE IN CHILDHOOD, 1989, 64 (09) :1235-1239
[2]   SALIVARY CONCENTRATION OF 17-HYDROXYPROGESTERONE IN MONITORING TREATMENT OF CONGENITAL ADRENAL-HYPERPLASIA [J].
ARISAKA, O ;
SHIMURA, N ;
NAKAYAMA, Y ;
ARISAKA, M ;
YABUTA, K .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1988, 113 (49) :1913-1915
[3]  
BROOK CGD, 1974, J PEDIATR-US, V85, P12, DOI 10.1016/S0022-3476(74)80277-5
[4]   Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency [J].
Charmandari, E ;
Johnston, A ;
Brook, CGD ;
Hindmarsh, PC .
JOURNAL OF ENDOCRINOLOGY, 2001, 169 (01) :65-70
[5]  
CUTLER GB, 1990, NEW ENGL J MED, V323, P1806
[6]   Development of a highly sensitive nonisotopic immunoassay for the determination of salivary 17-hydroxyprogesterone: Reference ranges throughout childhood and adolescence [J].
Dressendorfer, RA ;
Strasburger, CJ ;
Bidlingmaier, F ;
Klug, I ;
Kistner, A ;
Siebler, T ;
Kiess, W .
PEDIATRIC RESEARCH, 1998, 44 (05) :650-655
[7]   LINEAR GROWTH AND PUBERTAL DEVELOPMENT IN TREATED CONGENITAL ADRENAL-HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY [J].
GHALI, I ;
DAVID, M ;
DAVID, L .
CLINICAL ENDOCRINOLOGY, 1977, 6 (06) :425-436
[8]   Differential effects of hydrocortisone and dexamethasone on cortisol suppression in a child psychiatric population [J].
Gispen-de Wied, CC ;
Jansen, LMC ;
Wynne, HJ ;
Matthys, W ;
van der Gaag, RJ ;
Thijssen, JHH ;
van Engeland, H .
PSYCHONEUROENDOCRINOLOGY, 1998, 23 (03) :295-306
[9]   CONGENITAL ADRENAL-HYPERPLASIA - RENIN AND STEROID VALUES DURING TREATMENT [J].
GRANT, DB ;
DILLON, MJ ;
ATHERDEN, SM ;
LEVINSKY, RJ .
EUROPEAN JOURNAL OF PEDIATRICS, 1977, 126 (1-2) :89-96
[10]   Stability of salivary steroids:: the influences of storage, food and dental care [J].
Gröschl, M ;
Wagner, R ;
Rauh, M ;
Dörr, HG .
STEROIDS, 2001, 66 (10) :737-741